Trade Summary

8 months ago, Zanganeh Mahkam, serving as Co-CEO, 10% owner at Summit Therapeutics Inc. (SMMT), purchased 26,680 shares at $18.74 per share, for a total transaction value of $499,983.00. Following this transaction, Zanganeh Mahkam now holds 606,105,809 shares of SMMT.

The trade was executed on Tuesday, October 21, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 23, 2025 at 12:06 PM ET, 2 days after the trade was made.

Summit Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.